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Abstract 
Purpose: To test the hypothesis that refractive errors such as myopia and hyperopia cause 
an increased risk of age-related macular degeneration (AMD), and to quantify the degree of 
risk. 
Design: Two-sample Mendelian randomization analysis of data from a genome-wide 
association study. 
Participants: As instrumental variables for refractive error, 126 genome-wide significant 
genetic variants identified by the CREAM consortium and 23andMe Inc. were chosen. The 
association with refractive error for the 126 variants was obtained from a published study for 
a sample of n=95,505 European ancestry participants from UK Biobank. Association with 
AMD for the 126 genetic variants was determined from a genome-wide association study 
(GWAS) published by the International Age-related Macular Degeneration Genomics 
consortium of n=33,526 (16,144 cases and 17,832 controls) European ancestry participants. 
Methods: Two-sample Mendelian randomization analysis was used to assess the causal role 
of refractive error on AMD risk, using the 126 genetic variants associated with refractive 
error as instrumental variables, under the assumption that the relationship between 
refractive error and AMD risk is linear. 
Main Outcome Measures: The risk AMD caused by a 1 diopter (D) change in refractive error. 
Results: Mendelian randomization analysis suggested that refractive error had very limited 
influence on the risk of AMD. Specifically, a 1 D more hyperopic refractive error was 
associated with an OR=1.080 (95% CI: 1.021 to 1.142, P=0.007) increased risk of AMD. 
MR-Egger, MR-PRESSO, weighted median, and Phenoscanner-based sensitivity analyses 
detected minimal evidence to suggest that this result was biased by horizontal pleiotropy. 
Conclusions: Under the assumption of a linear relationship between refractive error and the 
risk of AMD, myopia and hyperopia only minimally influence the causal risk for AMD. Thus, 
inconsistently-reported strong associations between refractive error and AMD are likely to be 
the result of non-causal factors, such as stochastic variation, confounding or selection bias. 
Abstract  (MUST be submitted as a separate file)
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Abstract 
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increased risk of age-related macular degeneration (AMD), and to quantify the degree of risk. 
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with an OR=1.080 (95% CI: 1.021 to 1.142, P=0.007) increased risk of AMD. MR-Egger, MR-
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Introduction 
Age-related macular degeneration (AMD) is amongst the leading causes of visual impairment 
worldwide, and the leading cause in economically developed countries such as the United 
Kingdom where it is responsible for over 50% of registered visual impairment.1 The socio-
economic burden due to AMD-related visual impairment is set to increase even further as the 
elderly population expands.2,3 AMD is a progressive condition that affects the macular region of 
the retina. The early stage is characterised by increasing drusen (number, size & confluence) 
and pigmentary abnormalities with vision usually minimally affected. Advanced disease may 
manifest either via gradual, progressive atrophy of the macula, or rapid development of sub-
retinal neovascularisation leading to oedema, haemorrhage and eventual scar formation. Both 
atrophic and neovascular forms are associated with contemporaneous, and often severe, 
adverse impacts on central vision. Currently, treatment is only available for the neovascular 
form of AMD; the most effective treatment involving the regular injection of Anti-VEGF drugs into 
the eye.4–6 The development of new treatments and therapies requires a better understanding of 
the aetiology and pathogenesis of AMD, so that disease mechanisms can be effectively 
targeted. Recognising causal risk factors for AMD is therefore key to this work.   
Whilst the aetiology of AMD is not fully understood, it is clear that the condition results from a 
combination of genetic and environmental factors, the identification of which has been important 
in informing the understanding of AMD pathogenesis.7,8 The principle risk factor for AMD is 
age.9–12 Of the additional known risk factors, genetic predisposition and smoking have been the 
most consistently and confidently identified – the latter having particular significance as the risk 
can be modified with intervention. A systematic review by Chakravarthy et al. identified 73 
potential risk factors for advanced AMD,9 covering environmental (e.g. UV/sun exposure), 
demographic (e.g. age, race/ethnicity), genetic (e.g Complement factor H), lifestyle (e.g. 
smoking, dietary fats & anti-oxidants), general health (e.g. cardiovascular disease) and ocular 
comorbidity (e.g. refractive error) factors. Nevertheless, few of these potential risk factors for 
AMD have been evaluated as part of a randomised control trial (RCT) designed to test for a 
causal role. Whilst RCTs are the gold standard for demonstrating causation, they are resource 
intensive and are not always practical; e.g. if a long-term intervention is required, an RCT may 
not be feasible, or if exposure to a risk factor poses a potential health risk, an RCT may be 
unethical.   
Refractive error, in particular hyperopia, has been suspected to increase the risk of AMD since 
at least the late 1970’s.13 However, despite research over many decades, the evidence from 
cross-sectional and cohort studies has been inconsistent.14,15 Standard cross-sectional 
‘observational studies’ are susceptible to confounding and therefore are unable to establish a 
casual association between an exposure (e.g. degree of refractive error) and an outcome (e.g. 
patient has AMD).16,17 Mendelian Randomization (MR) analyses have been proposed as a 
research method for drawing valid casual inferences using existing, cross-sectional 
datasets,16,18 either as an alternative to RCTs in circumstances when an RCT is not practical, or 
as a precursor before embarking on a lengthy and costly RCT.19 MR utilizes genetic variants 
that explain variation in an exposure as ‘instrumental variables’ 20 in order to quantify the effect 
of the exposure on the outcome independent of confounding factors that influence the 
exposure-outcome relationship. The ability to attribute a causal effect in MR depends primarily 
on three keys assumptions: (1) that the genetic variants are robustly associated with the 
exposure, (2) the genetic variants only affect the outcome via the exposure, and (3) the genetic 
variants do not exert effects on confounders of the exposure-outcome relationship. Here, we 
sought to test the hypothesis that refractive error has a causal impact on the risk of AMD by 
applying Mendelian randomization, using as instrumental variables genetic variants associated 
with refractive error in a recent, large-scale GWAS.  
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Methods 
The study design is a two sample Mendelian randomization utilising GWAS summary statistics 
from CREAM, 23andMe, UK Biobank and IAMDGC. Participants provided informed consent to 
take part in the respective studies, which adhered to the principles of the Declaration of 
Helsinki.21,22 The IRB (School of Optometry and Vision Sciences Research Audit Ethics 
Committee) provided a waiver confirming approval was not required as this was a retrospective 
analysis of data already in the public domain.   
Instrumental variables for refractive error 
Tedja et al.21 reported the largest GWAS meta-analysis for refractive error to date. The GWAS 
meta-analysis included data for n=160,420 participants of European ancestry from the CREAM 
consortium and the 23andMe personal genomics company. The CREAM consortium GWAS 
was performed for the trait ‘spherical equivalent refractive error’ (SER) whereas the trait 
analysed in the 23andMe GWAS was ‘age of diagnosis of myopia’ (AODM). Tedja et al. 
identified 161 lead variants, where a lead variant was defined as ‘the variant with the lowest p-
value in a 100-kb window of the outermost genome-wide-significant variant of that same 
region’.21 These 161 variants with P < 5 x 10-8 in the CREAM/23andMe GWAS were tested for 
replication in an independent sample of n=95,505 participants of European ancestry aged 37–
73 years old from UK Biobank who had no history of eye disorders23 All of the UK Biobank 
participants had phenotype information for SER measured using non-cycloplegic autorefraction 
in diopters (D). The mean  standard deviation age of the UK Biobank GWAS sample was 57.7  7.9 years, and 53.1% were female. A total of 149/161 variants provided independent evidence 
of replication in the UK Biobank sample (P < 0.05), after excluding one tri-allelic variant.21  From 
amongst these 149 variants, 18 (rs10003846, rs11723482, rs1207782, rs13069734, rs1550094, 
rs17400325, rs17837871, rs1994840, rs2276560, rs2326823, rs2573081, rs2823097, 
rs6903823, rs72621438, rs745480, rs7925340, rs79266634 and rs79953651) were excluded as 
potential instrumental variables for having a pairwise linkage disequilibrium (LD) r2 > 0.05 with 
another variant in the set and a further 2 markers (rs1983554 and rs931302) were excluded for 
having a Hardy Weinberg equilibrium test P < 0.05, leaving 129 independent variants. There 
were 24 palindromic single nucleotide polymorphisms (SNPs), i.e. SNPs with alleles A/T or C/G, 
amongst these 129 variants. To avoid the chance of incorrectly harmonizing alleles in the 2-
sample MR analysis 24 palindromic SNPs were replaced by proxies in high LD (r2 > 0.8); proxies 
were available for 21 of the 24 palindromic SNPs, leaving a final set of 126 variants which were 
used as instrumental variables for refractive error in the current study (no proxy was available 
for rs2908972, rs74764079 or rs807037). The degree of association with refractive error for the 
variants was taken from the UK Biobank replication sample, rather than the larger 
CREAM/23andMe discovery sample, since the trait analysed in the UK Biobank GWAS was 
SER for all participants. The summary statistics for the 126 refractive error instrumental 
variables are shown in Supplementary Table 1 (available at www.aaojournal.org). 
Association of instrumental variables with age-related macular degeneration 
Fritsche et al.22 reported a GWAS meta-analysis for AMD carried out by the International Age-
related Macular Degeneration Genomics Consortium (IAMDGC). This meta-analysis examined 
a ‘discovery sample’ of n=33,526 individuals (16,144 cases and 17,832 controls) recruited 
across 26 studies. AMD cases were defined as individuals with either (i) geographic atrophy 
and/or choroidal neovascularization in at least one eye and an age at first diagnosis ≥50 years
(‘advanced AMD’), or (ii) pigmentary changes in the RPE or more than five macular drusen of 
diameter 63μm or greater and age at first diagnosis ≥50 years (‘intermediate AMD’). Control 
participants had a mean  standard deviation age of 70.7  9.7 years and were free from 
advanced or intermediate AMD. The GWAS meta-analysis summary statistics reported by the 
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IAMDGC (http://csg.sph.umich.edu/abecasis/public/amd2015/) included the effect allele, 
reference allele, direction of effect (i.e. increased or decreased risk of AMD) and P-value. For 
MR analysis, the log(odds ratio) (log(OR)) and corresponding standard errors for this dataset 
were calculated as described by Davey Smith and Burgess.25 Of the 126 genetic variants 
selected as instrumental variables for refractive error, summary data for all 126 were available 
in the AMD GWAS dataset. 
Statistical analysis 
All analyses were carried out with R.26 Inverse variance-weighted (IVW) MR,27 under a 
multiplicative random-effects model, weighted median MR 28 and MR-Egger analyses29 were 
carried out with the MendelianRandomisation package.30 MR-PRESSO analysis was performed 
with the MRPRESSO package, with K=100,000 simulations.31 Scatter plots were generated with 
the ggplot2 package. I2 heterogeneity statistics were calculated using the metafor package.32
From amongst the 126 variants associated with refractive error selected as instrumental 
variables, those with known pleiotropic effects on additional traits were identified using 
Phenoscanner 33 with the settings P < 5 x 10-8 and inclusion of proxy variants in LD (r2 > 0.8) in 
Europeans. The Phenoscanner analysis identified 31 variants with known pleiotropic effects 
(Supplementary Table 1; available at www.aaojournal.org). The variance in refractive error 
explained by the 126 instrumental variables was assessed as described by Ghorbani Mojarrad 
et al.34 in a sample of n=1,516 unrelated female adults from the UK (mean  standard deviation 
age=44.6  4.4 years) whose refractive error was assessed by non-cycloplegic autorefraction. 
Statistical power was assessed as described by Brion et al.,35 using the online tool: 
http://cnsgenomics.com/shiny/mRnd/. 
Results 
One hundred and twenty-six genetic variants associated with refractive error were chosen as 
instrumental variables for refractive error. The 126 genetic variants explained 4.4% of the 
variance in refractive error in an independent sample of UK adults, and the F-statistic from the 
first stage of the MR analysis was 1544.0. Both of these findings suggested there was minimal 
risk of ‘weak instrument bias’.34 The study had 45% power to detect an OR=1.10 increased risk 
of AMD per 1 D more hyperopic refractive error, and 80% power to detect an OR=1.16 
increased risk. Hence, the study was well-powered to detect risks below OR=0.85 or above 
OR=1.15, but was not well powered to detect very small risks close to the null value. 
A quantile-quantile (QQ) plot for the 126 refractive error instrumental variables, designed to 
illustrate their association with AMD, demonstrated an excess of low P-values compared to that 
expected under the null hypothesis (Figure 1). In particular, two of the refractive error variants 
were very strongly associated with AMD risk: rs10760673, an intronic variant within the 
TGFBR1 gene (AMD risk P=4.59e-09), and rs6420484, a missense variant in the TSPAN10
gene (AMD risk P=4.11e-11). Both genetic loci were already well-known to be associated with 
AMD.22
<Figure 1 near here> 
A standard, inverse variance-weighted (IVW) MR analysis using all 126 genetic variants 
suggested that each 1.00 D change in refractive error in the direction of more hyperopia was 
associated with an approximately 8% increase in the risk of AMD (OR=1.080, 95% CI: 1.021 to 
1.142, P=0.007; Table 1 and Figure 2).  
<Figure 2 near here> 
<Table 1 near here> 
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The standard IVW MR analysis including all 126 genetic variants exhibited strong evidence of 
heterogeneity (Cochran Q=326.1, P=7.1e-20; I2= 61.6%), implying that the SNP-exposure vs. 
SNP-outcome relationship varied widely across variants. The most likely reason for such 
heterogeneity in an MR analysis is ‘horizontal’ pleiotropy.18 Hence, a series of sensitivity 
analyses were undertaken to examine the robustness of the IVW MR causal effect estimate 
(Tables 1-3). A weighted median-based MR analysis, which provides a valid causal effect 
estimate if up to half of the information is from invalid instrumental variables, produced a similar 
estimate to that obtained from the IVW MR but with weaker statistical support. Specifically, while 
the median-based MR estimate was consistent with the IVW MR estimate, the 95% confidence 
interval included the null value (OR=1.045, 95% CI: 0.982 to 1.111, P=0.164; Table 1), 
commensurate with the reduced statistical power of median-based MR compared to IVW MR.28
An MR-Egger analysis found negligible evidence of directional pleiotropy: MR-Egger 
intercept=1.003 (95% CI: 0.991 to 1.016). Repeating the above analyses after excluding the 2 
variants (rs10760673 and rs6420484) very strongly associated with AMD risk had minimal 
impact on the results (Table 2). In addition to the 2 variants associated with AMD, a 
Phenoscanner analysis 33 identified a further 29 genetic variants with known effects on traits 
unrelated to refractive error. MR analysis after exclusion of these 31 variants from the original 
set of 126 variants produced comparable findings to the original analyses (Table 3). For 
example, the IVW MR causal effect estimate was OR=1.069 (95% CI: 1.016 to 1.124, P=0.010). 
Heterogeneity was partially reduced in this analysis, compared to the original analysis with all 
126 variants (Cochran Q=161.6, P=1.81e-05; I2= 39.1%). Finally, an MR-PRESSO analysis 
identified 6 variants as pleiotropic outliers (Supplementary Table 1; available at 
www.aaojournal.org). After removal of these 6 variants, the MR-PRESSO causal effect estimate 
was OR=1.104 (95% CI: 1.054 to 1.157, P=8.12e-05).  
<Table 2 near here> 
<Table 3 near here> 
In summary, a wide range of MR analysis models all produced causal effect estimates close to 
the null, with the most highly statistically powered analysis estimating an approximately 8-10% 
increased risk of AMD per 1 D more hyperopic refractive error. 
Discussion 
We performed a two-sample MR analysis to determine if a causal relationship exists between 
refractive error and the risk of age-related macular degeneration, based on genetic data from 
populations with European ancestry. The results suggested that the SER does indeed have a 
causal relationship with AMD risk, albeit with the risk of AMD increasing by less than 10% per 
1 D increase in hyperopia. This study provides genetic evidence to support a causal link 
between refractive error and AMD risk, which while not as definitive as that obtained from an 
RCT, provides greater freedom from confounder bias than the risks reported in the 
observational epidemiological studies conducted to date.  
A meta-analysis carried out by Pan et al.14 suggested that each 1 D increase in hyperopia is 
associated with a 6–9% increased risk of AMD, based on pooled responses across 2 cohort and 
5 cross-sectional studies. A further meta-analysis by Li et al.15, using largely overlapping study 
samples as Pan et al.,14 perhaps unsurprisingly found a similarly increased risk of 6–10% per 
diopter increase in hyperopia. Both figures are consistent with the upper estimate found in our 
analyses, of an approximately 8-10% increased risk of AMD per diopter of hyperopia.  However, 
when making this comparison, it is important to note Pan et al.14 observed that – other than age 
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– many important confounders, such as smoking status, education level and socio-economic 
status were not accounted for across all the meta-analysed studies. Furthermore, neither meta-
analysis 14,15 limited inclusion to individuals of European ancestry, in contrast to our MR 
analysis.  
Various biologically plausible explanations have been proposed for the relationship between 
refractive error and AMD risk. Explanations previously explored include posterior vitreous 
detachment (PVD), the prevalence of which is greater in myopic eyes,36 which has been 
suggested to reduce the likelihood of neovascularisation 14,37 (with the PVD hypothesized as 
removing a barrier to diffusion of VEGF away from the macular). Also, the VEGF concentration 
in the retina have been reported to be lower in myopic vs. hyperopic eyes, leading Jonas et al.38
to propose that this reduced VEGF concentration may influence the risk of AMD. Yet these 
explanations are not consistent with the frequently-observed association between refractive 
error and early AMD as opposed to advanced AMD.9,14,15
Others, such as Pan et al.39 have discussed possible links between light exposure and refractive 
error, in this case speculating that spectacle lens wear for refractive error may reduce UV 
exposure, although they noted that only a small proportion of their study sample classified as 
having either myopia or hyperopia did not wear spectacles. Furthermore, Quigley et al.40
contended that spectacle lenses would have negligible filtering effect on the short wavelength 
visible light commonly linked to AMD risk. Quigley et al.40 proposed that overall retinal light 
exposure, which using two sperate methods was demonstrated to increased with hyperopic 
refractive error (by proxy of axial eye length), was a more likely potential mechanism by which 
refractive error may be linked to increased risk of AMD. 
In addition to arguments centering on the retina, a greater rigidity of the sclera in shorter, 
hyperopic eyes has also been proposed,14,39,41,42 since rigidity of the sclera has been identified 
as a risk factor in neovascular AMD.43 Finally, myopic eyes characteristically have thinner 
choroids than hyperopic eyes.44 While this might imply that the choroidal contribution to removal 
of photoreceptor phagocytosis breakdown products may be relatively impaired in myopic eyes,45
this is not borne out by the smaller size of drusen in myopic eyes.46,47
This work had a number of limitations. Firstly, while we took steps to minimize the risk of bias 
from the potential use of invalid instrumental variables (due, for example, to horizontal 
pleiotropy) by performing MR-Egger, MR-PRESSO and weighted median-based MR sensitivity 
analyses, we cannot completely rule out such bias. Secondly, we made the assumption of a 
linear relationship between refractive error and the risk of AMD. Again, while observational 
studies of axial eye length (a surrogate for refractive error) and AMD risk suggest that this 
assumption was reasonable, data from a very large case-control sample with information on 
both AMD status and refractive error would be required to test it formally.48 Thirdly, with regards 
to the instrumental variable assumptions necessary for a valid MR analysis, the 126 genetic 
variants used all demonstrated an association with refractive error in an independent replication 
sample (UK Biobank) distinct from the discovery sample (CREAM and 23andMe). The variants 
together explained 4.4% of the variance in refractive error in an additional, independent sample 
of participants. Thus, the variants satisfied the first MR assumption of displaying robust 
association with the exposure. There was evidence of heterogeneity in the genetic variant-
exposure vs. genetic variant-outcome relationship (Q=326.1,I2= 61.6%) in the analysis using all 
126 variants, suggesting that either the second and/or third MR assumptions were not met. The 
most likely reason for this was horizontal pleiotropy, i.e. variants conferring a risk of AMD 
through a pathway other than via a direct effect on refractive error. While the sensitivity 
analyses reduced the level of residual heterogeneity, they did not exclude it completely. 
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However, the similarity in the causal effect estimates obtained with the original IVW MR analysis 
and the various sensitivity analyses provides reassurance that much of the original 
heterogeneity did not appreciably bias the results. However, as mentioned above, we cannot 
completely rule out bias due to horizontal pleiotropy that was still present in all of our sensitivity 
analyses. Fourthly, theoretically a 2-sample MR study design is at risk of confounding due to 
population stratification (if an instrumental variable tags groups of individuals with different 
ancestries and these groups differ in the prevalence of the outcome16). Since all 126 
instrumental variables in the current study were associated with refractive error in UK Biobank 
participants carefully selected as having homogeneous European ancestry, and association with 
AMD was also assessed in a sample restricted to those of European ancestry, the risk of 
confounding due to population stratification is extremely low. 
In summary, Mendelian randomization analysis provided evidence that hyperopic eyes have an 
increased risk of AMD, but that the causal effect size is modest (OR=1.08 per diopter, P=0.007). 
This degree of protection is consistent with that estimated in two large meta-analyses of cross-
sectional and longitudinal observational studies (OR=1.06–1.10 per diopter), which implies that 
confounder bias did not strongly impact previous risk estimates in these two studies. The 
increasing prevalence of myopia 49 and consequent reduction in the prevalence of hyperopia 
may serve to partially counter the higher incidence of AMD due to increased life expectancy 50
across most of the world. Nevertheless, this work emphasizes that risk factors other than 
refractive error, such as smoking, have a much greater impact on AMD risk. 
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Figure captions 
Figure 1. Quantile-quantile plot illustrating observed level of association with AMD risk 
(negative log10 p-value) for 126 genetic variants used as instrumental variables for 
refractive error. Note the inflation of observed negative log10 p-values compared to that 
expected under the null hypothesis of no association with AMD risk. The red line is the line of 
unity and the grey shaded region is the 95% confidence interval expected under the null 
hypothesis. Each point represents an individual genetic variant. 
Figure 2. Graphical representation of 2-sample Mendelian randomization meta-analysis 
results. Each point represents an individual genetic variant (instrumental variable) with error 
bars indicating the standard error. The association of each genetic variant with refractive error 
(in units of diopters per copy of the risk allele) is plotted on the x-axis, and the association with 
AMD risk (log odds ratio) is plotted on the y-axis. The solid red line shows the fit from an inverse 
variance weighted (IVW) MR meta-analysis model, while the dashed red line shows the fit for an 
MR-Egger model. 
Table 1. Mendelian randomization causal effect estimate for the risk of AMD (odds ratio) per 1 
diopter more hyperopic refractive error. 
Table 2. Sensitivity analysis results for Mendelian randomization analyses after excluding 2 
variants (rs10760673 and rs6420484) strongly associated with AMD risk.  
Table 3. Sensitivity analysis results for Mendelian randomization analyses after excluding 31 
variants strongly associated with non-refractive error traits identified by Phenoscanner.  
Supplementary Table 1. is available in the Online Supplementary Material. 
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Table 1. Mendelian randomization causal effect estimate for the risk of AMD (odds ratio) 
per 1 diopter more hyperopic refractive error. 
Analysis Causal effect (OR per D) 95% Confidence interval P-value 
Inverse variance-weighted 1.080 1.021 to 1.142 0.007 
Weighted median 1.045 0.982 to 1.111 0.164 
MR-Egger 1.048 0.922 to 1.190 0.474 
Analysis Intercept 95% Confidence interval P-value
MR-Egger 1.003 0.991 to 1.016 0.609 
Table 1
Page 1 
Table 2. Sensitivity analysis results for Mendelian randomization analyses after 
excluding 2 variants (rs10760673 and rs6420484) strongly associated with AMD risk.  
Analysis Causal effect (OR per D) 95% Confidence interval P-value 
Inverse variance-weighted 1.085 1.033 to 1.140 0.001 
Weighted median 1.045 0.982 to 1.111 0.164 
MR-Egger (slope) 1.057 0.945 to 1.182 0.329 
Analysis Intercept 95% Confidence interval P-value
MR-Egger (intercept) 1.003 0.992 to 1.014 0.608 
Table 2
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Table 3. Sensitivity analysis results for Mendelian randomization analyses after 
excluding 31 variants strongly associated with non-refractive error traits identified by 
Phenoscanner.  
Analysis Causal effect (OR per D) 95% Confidence interval P-value 
Inverse variance-weighted 1.069 1.016 to 1.124 0.010 
Weighted median 1.046 0.980 to 1.117 0.175 
MR-Egger (slope) 1.060 0.949 to 1.182 0.301 
Analysis Intercept 95% Confidence interval P-value
MR-Egger (intercept) 1.001 0.990 to 1.012 0.865 
Table 3
Figure 1
Click here to download high resolution image
Figure 2
Click here to download high resolution image
TOC Statement (75 words)
This manuscript describes a Mendelian randomization analysis of publicly available genome 
wide association study data to test the hypothesis that refractive error causes an increased 
risk of age-related macular degeneration. The analysis suggested that a one diopter more 
hyperopic refractive error caused an 8-10% increased risk of age-related macular 
degeneration, assuming a linear relationship. Thus, past studies reporting large risks due to 
refractive error may have been subject to confounding bias.  
*Table of Contents Statement
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Supplementary Table 1. GWAS summary statistics for 126 genetic variants identified by the CREAM consortium and 23andMe. Association with refractive 
error in n=95,505 UK Biobank participants (Tedja et al. 2018
21
) and association with AMD risk in 16,144 cases and 17,832 controls from the IAMDGC 
(Fritsche et al.
22
).
Variant rsID 
Effect 
allele 
Non-effect 
allele 
Effect allele 
frequency 
Association with  
refractive error (D)
Association with  
AMD (logOR) 
Phenoscanner 
outlier 
MR-PRESSO 
outlier 
BETA SE P BETA SE P 
rs10100333 T C 0.612 -0.056 0.012 6.60E-06 -0.038 0.017 3.12E-02 Yes --- 
rs10122788 G A 0.432 -0.036 0.012 3.80E-04 -0.027 0.017 1.19E-01 --- --- 
rs10187371 T C 0.166 -0.04 0.016 3.00E-03 0.022 0.023 3.30E-01 --- --- 
rs10458138 A G 0.218 -0.067 0.014 6.30E-07 -0.004 0.021 8.37E-01 --- --- 
rs10511652 G A 0.592 -0.096 0.012 3.50E-18 -0.002 0.017 9.15E-01 --- --- 
rs1064583 G A 0.398 -0.088 0.012 2.90E-14 -0.067 0.017 1.26E-04 Yes --- 
rs10760673 A G 0.202 -0.072 0.014 3.40E-07 -0.124 0.021 4.59E-09 Yes Yes 
rs10853531 G A 0.786 -0.09 0.014 2.60E-10 -0.027 0.021 1.91E-01 Yes --- 
rs10880855 T C 0.504 -0.062 0.012 4.80E-08 0.023 0.017 1.86E-01 --- --- 
rs10887262 C T 0.292 -0.103 0.013 2.80E-15 0.003 0.019 8.93E-01 --- --- 
rs10919908 A G 0.387 -0.094 0.012 4.50E-17 0.003 0.018 8.52E-01 --- --- 
rs10948572 C T 0.655 -0.067 0.012 2.90E-08 0.012 0.018 5.11E-01 --- --- 
rs11088317 T C 0.295 -0.06 0.013 6.50E-06 0.01 0.019 5.82E-01 Yes --- 
rs11101263 T C 0.269 -0.094 0.013 2.20E-13 -0.063 0.019 1.09E-03 --- --- 
rs11118367 T C 0.45 -0.087 0.012 1.20E-13 0.018 0.017 3.03E-01 Yes --- 
rs11145465 A C 0.217 -0.09 0.014 1.00E-10 0.016 0.021 4.34E-01 --- --- 
rs11178469 T C 0.773 -0.049 0.014 2.60E-04 0.005 0.02 8.07E-01 --- --- 
rs11210537 G A 0.683 -0.107 0.012 1.40E-17 -0.006 0.018 7.29E-01 --- --- 
rs1150687 C T 0.395 -0.072 0.012 3.10E-10 0.021 0.017 2.19E-01 Yes --- 
rs11589487 G A 0.557 -0.075 0.012 2.20E-10 0.013 0.017 4.49E-01 --- --- 
rs11654644 T C 0.188 -0.077 0.015 9.50E-08 0.025 0.022 2.59E-01 --- --- 
rs117735470 A G 0.092 -0.092 0.02 5.20E-06 -0.06 0.029 4.00E-02 --- --- 
rs11802995 C A 0.227 -0.086 0.014 4.40E-11 -0.015 0.02 4.52E-01 --- --- 
rs11952819 T C 0.275 -0.032 0.013 4.00E-02 0.014 0.019 4.78E-01 --- --- 
Supplementary Table 1
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rs12193446 A G 0.904 -0.423 0.02 4.6E-106 -0.015 0.029 6.04E-01 --- --- 
rs1237670 G A 0.224 -0.089 0.014 1.10E-10 -0.014 0.02 4.92E-01 --- --- 
rs12451582 G A 0.64 -0.106 0.012 8.80E-18 -0.033 0.018 6.60E-02 --- --- 
rs12883788 C T 0.539 -0.078 0.012 4.90E-12 -0.015 0.017 3.65E-01 Yes --- 
rs12898755 G A 0.791 -0.114 0.014 1.40E-16 -0.043 0.021 3.93E-02 --- --- 
rs12965607 G T 0.152 -0.125 0.016 8.10E-16 -0.031 0.024 1.87E-01 --- --- 
rs1313240 C T 0.289 -0.098 0.013 2.00E-15 -0.068 0.019 2.84E-04 Yes --- 
rs1317537 T C 0.516 -0.087 0.012 4.00E-14 0.024 0.017 1.65E-01 --- --- 
rs1358684 C T 0.27 -0.04 0.013 5.50E-04 -0.01 0.019 6.19E-01 --- --- 
rs1359543 A G 0.648 -0.058 0.012 2.10E-06 0.002 0.018 9.25E-01 --- --- 
rs1381566 G T 0.19 -0.191 0.015 7.70E-40 -0.024 0.022 2.73E-01 --- --- 
rs14165 G A 0.692 -0.067 0.013 4.80E-08 -0.01 0.018 5.94E-01 --- --- 
rs1454776 G T 0.475 -0.058 0.012 2.00E-07 -0.032 0.017 6.27E-02 --- --- 
rs1532278 T C 0.4 -0.048 0.012 3.10E-05 0.036 0.017 3.89E-02 Yes --- 
rs1555075 C T 0.649 -0.077 0.012 4.10E-11 -0.013 0.018 4.81E-01 Yes --- 
rs1556867 T C 0.239 -0.109 0.014 4.20E-17 -0.02 0.02 3.18E-01 --- --- 
rs1649068 A C 0.449 -0.074 0.012 7.50E-11 -0.002 0.017 8.90E-01 Yes --- 
rs17032696 A C 0.814 -0.063 0.015 9.20E-05 -0.003 0.022 8.99E-01 --- --- 
rs17125093 A G 0.198 -0.076 0.015 1.30E-08 -0.029 0.021 1.78E-01 --- --- 
rs17274750 C A 0.098 -0.108 0.02 1.90E-08 -0.057 0.029 4.56E-02 --- --- 
rs17382981 T C 0.424 -0.063 0.012 4.10E-07 -0.019 0.017 2.81E-01 Yes --- 
rs1790165 C A 0.576 -0.074 0.012 1.80E-10 -0.003 0.017 8.40E-01 --- --- 
rs1928175 A G 0.561 -0.087 0.012 5.90E-15 -0.017 0.017 3.23E-01 Yes --- 
rs1954761 T C 0.371 -0.097 0.012 1.20E-16 0.018 0.018 3.13E-01 --- --- 
rs1969091 C A 0.71 -0.073 0.013 3.10E-09 0.009 0.019 6.18E-01 --- --- 
rs2150458 G A 0.575 -0.084 0.012 1.80E-13 -0.005 0.017 7.72E-01 --- --- 
rs2155413 A C 0.47 -0.097 0.012 1.10E-17 0.028 0.017 1.07E-01 --- --- 
rs2166181 G A 0.47 -0.1 0.012 5.80E-18 0.003 0.017 8.82E-01 --- --- 
rs2312538 G A 0.712 -0.057 0.013 1.20E-06 -0.048 0.019 1.12E-02 --- --- 
rs235770 T C 0.389 -0.074 0.012 4.80E-11 0.013 0.017 4.74E-01 Yes --- 
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rs2466574 G A 0.292 -0.069 0.013 9.70E-09 0.035 0.019 6.19E-02 Yes --- 
rs2573210 G A 0.195 -0.194 0.015 7.90E-43 0.061 0.022 4.65E-03 --- Yes 
rs2573232 T C 0.908 -0.159 0.02 1.20E-16 0.015 0.03 6.07E-01 --- --- 
rs2622646 C A 0.65 -0.083 0.012 2.30E-12 -0.019 0.018 2.77E-01 --- --- 
rs2761884 G T 0.546 -0.101 0.012 2.00E-18 -0.003 0.017 8.48E-01 Yes --- 
rs28471081 A G 0.792 -0.112 0.014 3.70E-14 0.008 0.021 7.10E-01 --- --- 
rs284818 T C 0.132 -0.093 0.017 1.60E-08 0.016 0.025 5.19E-01 --- --- 
rs28658452 A G 0.916 -0.085 0.021 5.80E-05 0.034 0.031 2.64E-01 --- --- 
rs297593 T C 0.288 -0.084 0.013 7.80E-11 -0.015 0.019 4.37E-01 --- --- 
rs3110134 G A 0.687 -0.066 0.013 5.00E-08 -0.023 0.018 2.19E-01 --- --- 
rs3138137 C A 0.514 -0.116 0.012 6.60E-25 -0.044 0.017 1.05E-02 --- --- 
rs34898258 T C 0.44 -0.076 0.012 2.40E-10 -0.034 0.017 4.84E-02 --- --- 
rs35337422 C A 0.146 -0.066 0.016 3.50E-05 0.066 0.024 6.45E-03 --- --- 
rs36024104 G A 0.191 -0.098 0.015 2.20E-12 0.024 0.022 2.66E-01 --- --- 
rs41393947 A G 0.141 -0.116 0.017 1.00E-12 -0.002 0.024 9.35E-01 Yes --- 
rs4237285 C T 0.535 -0.054 0.012 3.50E-06 -0.007 0.017 6.62E-01 --- --- 
rs4260345 C T 0.373 -0.055 0.012 2.20E-06 -0.008 0.018 6.65E-01 --- --- 
rs4764038 T G 0.267 -0.081 0.013 1.30E-09 -0.003 0.019 8.80E-01 --- --- 
rs4793501 T C 0.579 -0.081 0.012 3.70E-12 -0.003 0.017 8.64E-01 --- --- 
rs4795364 G A 0.252 -0.068 0.013 8.50E-08 -0.035 0.02 7.20E-02 Yes --- 
rs4808962 G A 0.169 -0.082 0.016 1.40E-08 0.032 0.023 1.64E-01 Yes --- 
rs4894529 G A 0.516 -0.037 0.012 2.00E-03 -0.032 0.017 6.47E-02 Yes --- 
rs522774 A C 0.741 -0.112 0.013 2.70E-18 0.009 0.019 6.42E-01 --- --- 
rs5442 A G 0.07 -0.267 0.023 1.20E-33 -0.087 0.033 8.86E-03 --- --- 
rs55885222 A C 0.365 -0.037 0.012 2.60E-03 0 0.018 9.99E-01 --- --- 
rs56014528 G T 0.846 -0.093 0.016 9.10E-10 -0.006 0.024 8.06E-01 --- --- 
rs56055503 A G 0.778 -0.061 0.014 8.00E-06 0.009 0.021 6.64E-01 --- --- 
rs56075542 T G 0.549 -0.103 0.012 1.30E-18 -0.005 0.017 7.72E-01 --- --- 
rs61875120 C T 0.22 -0.11 0.014 2.60E-16 -0.06 0.021 3.57E-03 Yes --- 
rs62070229 G A 0.187 -0.129 0.015 1.30E-18 0.01 0.022 6.53E-01 Yes --- 
Page 4 
rs634990 C T 0.488 -0.245 0.012 1.1E-103 -0.054 0.017 1.59E-03 --- --- 
rs6420484 A G 0.356 -0.091 0.012 4.30E-15 0.117 0.018 4.11E-11 Yes Yes 
rs6433704 G T 0.412 -0.121 0.012 5.60E-24 -0.028 0.017 1.03E-01 --- --- 
rs6495367 A G 0.418 -0.149 0.012 7.20E-37 0.006 0.017 7.29E-01 Yes --- 
rs6753137 T C 0.432 -0.057 0.012 1.40E-06 -0.029 0.017 9.43E-02 --- --- 
rs7042950 G A 0.224 -0.116 0.014 2.90E-18 -0.021 0.02 3.05E-01 --- --- 
rs7107014 C A 0.516 -0.047 0.012 1.10E-04 0.004 0.017 8.21E-01 --- --- 
rs7122817 G A 0.518 -0.072 0.012 1.10E-10 -0.009 0.017 5.81E-01 --- --- 
rs7143516 T G 0.256 -0.101 0.013 3.70E-14 0.025 0.02 2.02E-01 --- --- 
rs7188859 C T 0.366 -0.175 0.012 3.00E-49 -0.026 0.018 1.44E-01 --- --- 
rs7207217 A G 0.382 -0.043 0.012 1.20E-03 0.008 0.018 6.48E-01 --- --- 
rs72655575 C A 0.789 -0.07 0.014 7.10E-07 -0.028 0.021 1.82E-01 --- --- 
rs7337610 T C 0.373 -0.071 0.012 7.70E-09 -0.045 0.018 1.01E-02 --- --- 
rs73730144 C A 0.012 -0.311 0.053 7.00E-10 0.145 0.077 6.04E-02 --- --- 
rs7449443 T G 0.602 -0.037 0.012 2.70E-04 0.001 0.017 9.37E-01 --- --- 
rs7554219 C T 0.342 -0.097 0.012 1.10E-16 0.06 0.018 8.16E-04 --- Yes 
rs7584258 A G 0.752 -0.07 0.013 2.00E-07 -0.009 0.02 6.63E-01 Yes --- 
rs7624084 T C 0.557 -0.098 0.012 6.50E-17 -0.06 0.017 4.68E-04 Yes --- 
rs7662551 G A 0.255 -0.096 0.013 6.00E-12 -0.002 0.02 9.28E-01 --- --- 
rs7667446 C T 0.184 -0.104 0.015 7.50E-13 -0.012 0.022 5.73E-01 --- --- 
rs7737179 A G 0.224 -0.059 0.014 1.00E-05 -0.06 0.02 3.43E-03 Yes --- 
rs7744813 A C 0.586 -0.216 0.012 1.00E-75 0.004 0.017 8.26E-01 --- --- 
rs7747 C T 0.802 -0.115 0.015 7.70E-16 0.012 0.021 5.90E-01 --- --- 
rs7829127 A G 0.794 -0.135 0.014 3.10E-22 -0.011 0.021 6.13E-01 --- --- 
rs7895108 T G 0.372 -0.126 0.012 1.10E-27 -0.003 0.018 8.48E-01 --- --- 
rs7933504 G A 0.292 -0.05 0.013 1.40E-05 -0.035 0.019 6.25E-02 --- --- 
rs7941828 C T 0.64 -0.044 0.012 1.90E-04 -0.015 0.018 3.86E-01 Yes --- 
rs7968679 G A 0.316 -0.076 0.013 4.20E-10 0.003 0.018 8.87E-01 --- --- 
rs7971334 T G 0.303 -0.029 0.013 3.30E-02 -0.044 0.019 1.67E-02 --- --- 
rs8032307 C T 0.874 -0.128 0.018 1.50E-11 -0.04 0.026 1.23E-01 --- --- 
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rs8073754 T C 0.174 -0.105 0.015 5.30E-13 0.002 0.023 9.12E-01 --- --- 
rs8076642 G A 0.596 -0.055 0.012 8.60E-06 -0.022 0.017 2.10E-01 Yes --- 
rs8137714 G T 0.214 -0.04 0.014 2.20E-02 0.069 0.021 9.78E-04 --- --- 
rs837323 C T 0.525 -0.091 0.012 5.30E-16 0.011 0.017 5.32E-01 --- --- 
rs9295499 C A 0.68 -0.071 0.012 6.20E-09 -0.017 0.018 3.42E-01 --- --- 
rs9388766 C T 0.697 -0.048 0.013 4.10E-05 0.038 0.019 3.81E-02 Yes --- 
rs9416017 T C 0.362 -0.057 0.012 6.00E-06 -0.013 0.018 4.69E-01 --- --- 
rs9516194 G A 0.5 -0.044 0.012 2.60E-05 -0.017 0.017 3.19E-01 --- --- 
rs9517964 C T 0.427 -0.108 0.012 3.40E-20 -0.009 0.017 5.89E-01 --- --- 
rs9547035 G T 0.267 -0.095 0.013 1.60E-13 0.011 0.019 5.54E-01 --- --- 
rs9680365 A G 0.034 -0.078 0.032 1.70E-02 -0.082 0.047 8.08E-02 --- --- 
rs9681162 C T 0.289 -0.088 0.013 6.30E-13 -0.004 0.019 8.37E-01 --- --- 
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